Evidence map›Paper›PMID 36679899›Full record

ArticleVaccines2022

Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study.

Bálint Drácz, Veronika Müller, István Takács, Krisztina Hagymási, Elek Dinya, Pál Miheller, Attila Szijártó, Klára Werling

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bálint DráczDepartment of Surgery, Transplantation and Gastroenterology, Semmelweis University, 1083 Budapest, Hungary.ORCID 0000-0001-6034-6669
Veronika MüllerDepartment of Pulmonology, Semmelweis University, 1083 Budapest, Hungary.ORCID 0000-0002-1398-3187
István TakácsDepartment of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary.
Krisztina HagymásiDepartment of Surgery, Transplantation and Gastroenterology, Semmelweis University, 1083 Budapest, Hungary.
Elek DinyaDigital Health Department, Semmelweis University, 1083 Budapest, Hungary.
Pál MihellerDepartment of Surgery, Transplantation and Gastroenterology, Semmelweis University, 1083 Budapest, Hungary.
Attila SzijártóDepartment of Surgery, Transplantation and Gastroenterology, Semmelweis University, 1083 Budapest, Hungary.
Klára WerlingDepartment of Surgery, Transplantation and Gastroenterology, Semmelweis University, 1083 Budapest, Hungary.ORCID 0000-0002-8567-7947
Semmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with cirrhosis are vulnerable to hepatic decompensation events and death following COVID-19 infection. Therefore, primary vaccination with COVID-19 vaccines is fundamental to reducing the risk of COVID-19 related deaths in patients with cirrhosis. However, limited data are available about the effectiveness of mRNA vaccines compared to other vaccines. The aim of our study was to investigate the efficacy of mRNA vaccines versus other vaccines in cirrhosis. In this retrospective study, we compared clinical characteristics and vaccine effectiveness of 399 COVID-19 patients without cirrhosis (GROUP A) to 52 COVID-19 patients with cirrhosis (GROUP B). 54 hospitalised cirrhosis controls without COVID-19 (GROUP C) were randomly sampled 1:1 and matched by gender and age. Of the cirrhosis cases, we found no difference (

Indexed as

COVID-19 vaccinationliver cirrhosismRNA vaccinesvaccine effectiveness

Identifiers

PMID36679899
PMCPMC9861308
OpenAlexW4313243962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.